Study reveals targetable mechanism behind high-risk predisposition gene in pediatric medulloblastoma

Discoveries announced today by St. Jude Children’s Research Hospital provide a scientific rationale for the targeted treatment of a type of pediatric medulloblastoma. Children who inherit a deficient ELP1 gene have an increased risk of developing SHH-medulloblastoma, a subtype of a malignant pediatric brain tumor.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup